Antibiotic Regulatory Affairs

Ever since the discovery of antibiotics, the quality of human life greatly improved in the 20th century. The discovery of penicillin transformed the medicine industry and initiated a search for a better antibiotic every time resulting in several synthetic and semi-synthetic antibiotics. Beginning with the 1937 sulfa drug tragedy, the drug regulations had a parallel growth along with the antibiotics and the antibiotic-based generic Pharma industries. Several regulatory aspects involved with these industries have been discussed along with the complexity of the market, issues that could affect their growth, their struggle for quality, and their compliance with the tightened regulations. With the skyrocketing commercialization of antibiotics through generics and the leveraging technologic renaissance, generic industries are involved in providing maximum safer benefits for the welfare of the people, highlighting its need today.

 

    Related Conference of Antibiotic Regulatory Affairs

    March 17-18, 2025

    54th World Congress on Microbiology

    Berlin, Germany
    July 28-29, 2025

    17th International Virology Summit

    Berlin, Germany
    August 25-26, 2025

    6th International Conference on Molecular Microbiology

    Singapore City, Singapore
    September 22-23, 2025

    13th World Congress and Expo on Applied Microbiology

    Dubai, UAE

    Antibiotic Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in